The Newborn Screening market size is USD 1.3 Bn in 2026.
The Newborn Screening market is projected to grow at a CAGR of 5% by 2033.
The Newborn Screening market growth drivers include rising prevalence of congenital disorders, expanding government screening programs, and advancements in screening technologies such as DBS and molecular assays.
North America is a dominating region for Newborn Screening market.
PerkinElmer, Inc., Thermo Fisher Scientific, Abbott Laboratories, Roche Diagnostics, and Danaher Corporation are some leading industry players in the Newborn Screening market.